Phase I trial of sorafenib following liver transplantation in patients with high-risk hepatocellular carcinoma.
Siegel AB, El-Khoueiry AB, Finn RS, Guthrie KA, Goyal A, Venook AP, Blanke CD, Verna EC, Dove L, Emond J, Kato T, Samstein B, Busuttil R, Remotti H, Coffey A, Brown RS Jr.
Siegel AB, et al. Among authors: coffey a.
Liver Cancer. 2015 Mar;4(2):115-25. doi: 10.1159/000367734.
Liver Cancer. 2015.
PMID: 26020033
Free PMC article.